Zacks Research downgraded shares of Clariant (OTCMKTS:CLZNY – Free Report) from a hold rating to a strong sell rating in a research report sent to investors on Wednesday morning,Zacks.com reports.
Separately, The Goldman Sachs Group cut shares of Clariant from a “buy” rating to a “sell” rating in a research note on Tuesday, February 10th. Two analysts have rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce”.
Check Out Our Latest Research Report on Clariant
Clariant Price Performance
Clariant Company Profile
Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.
The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.
Featured Stories
- Five stocks we like better than Clariant
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.
